Current Edition

News

AstraZeneca’s Eplontersen meets endpoints in critical phase 3 trial

Eplontersen significantly improved patient-reported quality of life following successful research. Positive results from the NEURO-TTRansform phase 3 trial in patients with hereditary transthyretin-mediated amyloid polyneuropathy …

Continue Reading →
News

University of Strathclyde develops 3D breast cancer screening tool

Pre-clinical screening technology could increase cancer test numbers by 50 times. A new screening tool developed at the University of Strathclyde could increase the number …

Continue Reading →
News

RMI’s COVID-19 vaccine partnership with Acacium proves a success

The joint aim of the companies was to provide vaccines to vulnerable communities. Remote Medical International (RMI) – which specialises in protecting the health of …

Continue Reading →
News

Blood vessel breakthrough is major step towards Alzheimer’s treatment

The discovery may lead to the development of drugs that halt disease progression and stop memory loss. According to research funded by the British Heart …

Continue Reading →
News

OWEN MUMFORD APPOINTS NEW DIRECTOR OF RESEARCH AND DEVELOPMENT

WOODSTOCK – OXFORDSHIRE, England, 16th June 2022 – Owen Mumford, a global leader in the design, manufacture and advancement of medical devices today announced that …

Continue Reading →
News

Humanigen Enters into Agreement with PCI Pharma Services as Part of Preparations for Commercialization in the United Kingdom

SHORT HILLS, NJ. June 16, 2022–(BUSINESS WIRE)– Humanigen, Inc. (Nasdaq: HGEN) (“Humanigen”), a late-stage clinical biopharmaceutical company focused on preventing and treating an immune hyper-response …

Continue Reading →
News

Bachem and Eli Lilly link up to advance oligonucleotide products

The agreement will see the two companies expand current oligonucleotide technologies. Bachem – the Swiss pharmaceutical company – has partnered with Eli Lilly, to further …

Continue Reading →
News

Vertex trial for hypoglycaemia therapy shows early promise

New data now reveals significant increases in the blood glucose time-in-range compared to baseline, following VX-880 dosage. Vertex Pharmaceuticals has provided additional data on patients …

Continue Reading →
News

Daiichi Sankyo and AstraZeneca’s Enhertu delivers promising trial results

Enhertu reduced the risk of disease progression or death compared to chemotherapy in certain patients with metastatic breast cancer. Daiichi Sankyo and AstraZeneca’s breast cancer …

Continue Reading →
News

Cambridge Pharma promises to boost drug development

A new facility opens in Cambridge Research Park offering pharmaceutical development services. Pharma and medical device manufacturer, SMC, has announced the opening of Cambridge Pharma …

Continue Reading →